Price Chart

Profile

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Europe and Rest of the World. The company earns revenue from one source, the Reducer.
URL https://www.neovasc.com
Investor Relations URL http://www.neovasc.com/neovasc-investment/
HQ State/Province British Columbia
Sector  
Industry  
Equity Style Small Cap/Growth
Next Earnings Release N/A
Last Earnings Release Mar. 10, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Europe and Rest of the World. The company earns revenue from one source, the Reducer.
URL https://www.neovasc.com
Investor Relations URL http://www.neovasc.com/neovasc-investment/
HQ State/Province British Columbia
Sector  
Industry  
Equity Style Small Cap/Growth
Next Earnings Release N/A
Last Earnings Release Mar. 10, 2022
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A